Corpus ID: 89618086

Therapy for Gastroenteropancreatic Neuroendocrine Tumors: drug evaluation reports review in Spain.

@article{Darb2019TherapyFG,
  title={Therapy for Gastroenteropancreatic Neuroendocrine Tumors: drug evaluation reports review in Spain.},
  author={Josep Darb{\`a} and Meritxell Ascanio},
  journal={Neuro endocrinology letters},
  year={2019},
  volume={39 8},
  pages={
          537-543
        }
}
  • Josep Darbà, Meritxell Ascanio
  • Published in Neuro endocrinology letters 2019
  • Medicine
  • OBJECTIVES In Spain it is necessary to conduct additional studies to determine place in therapy and cost-effectiveness of a drug. The main objective of this study is to identify all drug assessments and health technology assessment reports of the drugs for gastroenteropancreatic (GEP) neuroendocrine tumors (NET) at a national, regional and hospital level and to summarize the efficacy in terms of outcome measures, adverse events, economic impact and final recommendations. METHODS A search was… CONTINUE READING

    Create an AI-powered research feed to stay up to date with new papers like this posted to ArXiv